Bradley Herrick
Victorville, CANPI 1700035235
Payments from drug & device makers
Across 173 payments — averaging $21.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$638
- LEO Pharma Inc.$588
- Pfizer$394
- Regeneron Healthcare Solutions, Inc.$324
- UCB, Inc.$205
- Galderma Laboratories, L.p.$203
- plus $1K from 18 others
What the payments were for
- Food & beverage$3,62297%
- Education$1293%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 33 | $638 |
| LEO Pharma Inc. | 34 | $588 |
| Pfizer | 14 | $394 |
| Regeneron Healthcare Solutions, Inc. | 10 | $324 |
| UCB, Inc. | 10 | $205 |
| Galderma Laboratories, L.p. | 5 | $203 |
| Novartis | 19 | $175 |
| Sanofi | 3 | $168 |
| Johnson & Johnson | 8 | $159 |
| Genentech USA, Inc. | 4 | $147 |
| Janssen Scientific Affairs, LLC | 1 | $115 |
| Dermira, Inc. | 4 | $107 |
| EPI Health, LLC | 4 | $92 |
| Lilly USA, LLC | 4 | $79 |
| Organogenesis Inc. | 4 | $63 |
| Sanofi-aventis U.S. LLC | 3 | $54 |
| Amgen | 1 | $50 |
| Prugen, Inc. Pharmaceuticals | 3 | $39 |
| Nabriva Therapeutics, PLC | 2 | $35 |
| Biofrontera Inc. | 2 | $34 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $29 |
| DUSA Pharmaceuticals, Inc. | 1 | $24 |
| Merz North America, Inc. | 1 | $21 |
| Strata Skin Sciences, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$249
- EPIDUO FORTE$127
- EUCRISA$125
- Tremfya$115
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.